.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
PAX is stocked at 633 licensed dispensaries across California, New York, and 11 other states, 224 of them in California, with the deepest coverage in Los Angeles, San Diego, San Francisco, Sacramento, and Santa Ana. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Vapor Pens accounted for 93.40% share with a 4.28% year-over-year increase and a 2.21% month-over-month rise, while Edible held 6.59% share with a 130.31% year-over-year surge but a 14.55% month-over-month decline; Concentrates remained marginal at 0.01% share with a 42.33% year-over-year drop yet a 65.62% month-over-month rebound. Brand-wide average price fell 10.78% year over year to $39.01, contrasting with Vapor Pens’ higher $41.88 average and Edible’s $19.77, indicating mix pressure alongside premium positioning in the core. The pattern implies PAX is consolidating around Vapor Pens for stability while treating Edible as a high-beta adjunct that inflates year-over-year growth but introduces month-to-month volatility.
With Vapor Pens ranked 3 in Colorado, the 2.21% month-over-month gain in its 93.40% revenue anchor signals defensible placement, whereas Edible’s 14.55% month-over-month drawdown against a 130.31% year-over-year jump points to episodic activation rather than durable share capture. The 10.78% year-over-year price compression alongside a 4.28% Vapor Pens growth rate and a 65.62% month-over-month lift in a near-zero-share Concentrates line suggests PAX is trading price for velocity in its core while selectively testing peripheral categories for incremental reach. The implication is a positioning centered on scale efficiency in Vapor Pens, using price and assortment levers to sustain rank while keeping optionality in Edible and Concentrates without diverting focus from the core.
Competitive Landscape
PAX sits at rank #3 in Colorado Vapor Pens in August 2026, unchanged YoY from #3, while holding rank #3 for the past three months and coming off a peak at #1 in March 2026; meanwhile, Spherex held #1 YoY and remains #1, and Batch Extracts climbed from #4 YoY to #2 with a 72.9% YoY sales increase. Further pressure comes from Jetty Extracts, which moved from #6 YoY to #4 on 56.2% YoY growth, and Green Dot Labs, which improved from #8 YoY to #5 with 58.5% YoY growth; the pattern implies PAX’s flat rank at #3 amidst upward mobility below it signals a narrowing buffer and a need to defend share against brands accelerating into the #2–#4 corridor.
Notable Products
Heirloom Peach Live Rosin Gummies 10-Pack (100mg) posted the steepest decline in August 2026 at -15.1% MoM while sitting at rank 10, and Wild Strawberry Live Rosin Gummies 10-Pack (100mg) also fell -10.2% MoM at rank 7, indicating edible momentum cooled even as Trip - Kushberry OG Rosin Diamonds Disposable (1g) gained 19.6% MoM at rank 4. Trip - Blue Dream Fresh Pressed Live Rosin Diamonds Disposable Pax Era Pod (1g) remained rank 1 despite a -7.9% MoM dip, while Trip - Maui Wowie Live Resin Diamonds Disposable Pax Era Pod (1g) in rank 2 grew 7.5% MoM, and five of the top ten are Vapor Pens, concentrating mix away from edibles. Trip- Grapefruit Haze Live Rosin Diamonds Disposable (1g) advanced 8.7% MoM at rank 5, while Trip - Northern Lights Live Rosin Diamonds Disposable Pax Era Pod (1g) in rank 3 edged up 1.7% MoM, implying the Trip vapor lineup is absorbing demand that is exiting the Live Rosin gummy SKUs. The pattern implies PAX’s commercial direction is skewing toward higher-velocity pens, with edibles acting as a secondary portfolio lever rather than a growth engine.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
